Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Aug 2009):

The role of serotonin in nonnormative risky choice: the effects of tryptophan supplements on the "reflection effect" in healthy adult volunteers.

Full Abstract

Risky decision-making involves weighing good and bad outcomes against their probabilities in order to determine the relative values of candidate actions. Although human decision-making sometimes conforms to rational models of how this weighting is achieved, irrational (or nonnormative) patterns of risky choice, including shifts between risk-averse and risk-seeking choices involving equivalent-value gambles (the "reflection effect"), are frequently observed. In the present experiment, we investigated the role of serotonin in decision-making under conditions of uncertainty. Fifteen healthy adult volunteers received a treatment of 3 g per day of the serotonin precursor, tryptophan, in the form of dietary supplements over a 14-day period, whereas 15 age- and IQ-matched control volunteers received a matched placebo substance. At test, all participants completed a risky decision-making task involving a series of choices between two simultaneously presented gambles, differing in the magnitude of their possible gains, the magnitude of their possible losses, and the probabilities with which these outcomes were delivered. Tryptophan supplements were associated with alterations in the weighting of gains and small losses perhaps reflecting reduced loss-aversion, and a marked and significant diminution of the reflection effect. We conclude that serotonin activity plays a significant role in nonnormative risky decision-making under conditions of uncertainty.

 

Author information

Author/s: Murphy, Susannah E (SE); Longhitano, Carlo (C); Ayres, Rachael E (RE); Cowen, Philip J (PJ); Harmer, Catherine J (CJ); Rogers, Robert D (RD);

Affiliation: University of Oxford, United Kingdom.

Grants: (Agency:Biotechnology and Biological Sciences Research Council) ; (Agency:Wellcome Trust)

Journal and publication information

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal: Journal of cognitive neuroscience (J Cogn Neurosci), published in United States. (Language: eng)

Reference: 2009-Sep; vol 21 (issue 9) : pp 1709-19

Dates: Created 2009/07/13; Completed 2009/10/16;

PMID: 18823228, status: MEDLINE (last retrieval date: 10/16/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Antidepressive Agents, Second-Generation (0) ; Serotonin (50-67-9) ; Tryptophan (73-22-3)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

5/19/1983
7/30/2007
Higher Relevance Score (100)
Lower Relevance Score (67)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index